Related Experiment Video
Updated: Feb 14, 2026
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: February 23, 2024
Stenotrophomonas maltophilia: From trivial to grievous
Lipika Singhal1, Parvinder Kaur2, Vikas Gautam3
1Department of Microbiology, Government Medical College and Hospital, Chandigarh, India.
Abstract:
Stenotrophomonas maltophilia, once regarded as an organism of low virulence, has evolved as a significant opportunistic pathogen causing severe human infections in both hospital and community settings, especially amongst highly debilitated patients. Globally, S. maltophilia ranks third amongst the four most common pathogenic non-fermenting Gram-negative bacilli (NFGNBs), others being Pseudomonas aeruginosa, Acinetobacter baumannii and Burkholderia cepacia complex (Bcc). The worth of accurate identification of S. maltophilia comes to the forefront as it needs to be differentiated from other NFGNBs such as Acinetobacter, P. aeruginosa and Bcc due to its inherently contrasting antibiotic susceptibility pattern. Consequently, its correct identification is essential as no single drug is amply effective against all NFGNBs, which hinders initiation of appropriate empirical treatment resulting in increased morbidity and mortality.
Insights
Stenotrophomonas maltophilia is an opportunistic pathogen causing severe infections. Accurate identification is crucial due to its unique antibiotic resistance, differentiating it from other Gram-negative bacilli to guide effective treatment.
Area of Science:
- Medical microbiology
- Infectious diseases
Background:
- Stenotrophomonas maltophilia is an emerging opportunistic pathogen.
- It is a leading cause of hospital-acquired infections, particularly in immunocompromised individuals.
- It ranks third among pathogenic non-fermenting Gram-negative bacilli (NFGNBs).
Purpose of the Study:
- To highlight the clinical significance of Stenotrophomonas maltophilia.
- To emphasize the importance of accurate identification and differentiation from other NFGNBs.
- To underscore the impact of correct identification on empirical treatment strategies.
Main Methods:
- Literature review on Stenotrophomonas maltophilia infections.
- Comparative analysis of Stenotrophomonas maltophilia with other NFGNBs (Pseudomonas aeruginosa, Acinetobacter baumannii, Burkholderia cepacia complex).
- Discussion of antibiotic susceptibility patterns.
Main Results:
- Stenotrophomonas maltophilia exhibits distinct antibiotic susceptibility.
- Misidentification can lead to inappropriate empirical treatment.
- Accurate differentiation is essential for patient outcomes.
Conclusions:
- Accurate identification of Stenotrophomonas maltophilia is critical for effective patient management.
- Differentiating S. maltophilia from other NFGNBs is vital due to differing antibiotic profiles.
- Timely and correct diagnosis improves treatment efficacy and reduces mortality.
